Invesco NASDAQ Biotech UCITS ETF Acc - USD Stock

ETF

SBIO

IE00BQ70R696

End-of-day quote Berne S.E. 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Invesco NASDAQ Biotech UCITS ETF Acc - USD -.--% -.--%
Dynamic Chart

Investment objective

The Invesco NASDAQ Biotech UCITS ETF Acc aims to provide the performance of the NASDAQ Biotechnology Index, after fees. The index comprises biotechnology and pharmaceuticals companies (as defined by ICB) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements. They are then weighted by modified market capitalisation: the largest five constituents are capped at 8%; the remaining constituents are capped at 4%. The index is rebalanced quarterly and reviewed annually in December.
In partnership with
TrackInsight

ETF Ratings

Description

IE00BQ70R696
Total Expense Ratio 0.40%
Asset Class
Sector
Size
Currency
Provider
Underlying NASDAQ Biotechnology Total Return Index - USD

Features and characteristics

Jurisdiction
Replication Method
Replication Model
Date of creation
2014-11-05
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-04-29 )

AuM (EUR) 301 M€
AuM 1M 581 M€
AuM 3 months 553 M€
AuM 6 months 474 M€
AuM 12 months 553 M€
  1. Stock Market
  2. ETF
  3. SBIO ETF
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW